Christopher Gyngell

Learn More
To cite this article: Sarah Chan, Peter J. Donovan, Thomas Douglas, Christopher Gyngell, John Harris, Robin Lovell-Badge, Debra J. H. Mathews, Alan Regenberg & On Behalf of the Hinxton Group (2015) Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement, The American Journal of Bioethics, 15:12, 42-47, DOI:(More)
The publication of the first study to use gene editing techniques in human embryos (Liang et al., 2015) has drawn outrage from many in the scientific community. The prestigious scientific journals Nature and Science have published commentaries which call for this research to be strongly discouraged or halted all together (Lanphier et al., 2015; Baltimore et(More)
Germline Gene Editing (GGE) has enormous potential both as a research tool and a therapeutic intervention. While other types of gene editing are relatively uncontroversial, GGE has been strongly resisted. In this article, we analyse the ethical arguments for and against pursuing GGE by allowing and funding its development. We argue there is a strong case(More)
  • 1